Estrogen induces RAD51C expression and localization to sites of DNA damage

References

• Ciccia A, Elledge SJ. The DNA damage response: making it safe to play with knives. Mol Cell 2010; 40:179-204; PMID:20965415; http://dx.doi.org/10.1016/j.molcel.2010.09.019
   PubMed Web of Science ®Google Scholar
• Jackson SP, Bartek J. The DNA-damage response in human biology and disease. Nature 2009; 461:1071-8; PMID:19847258; http://dx.doi.org/10.1038/nature08467
   PubMed Web of Science ®Google Scholar
• Narod SA, Foulkes WD. BRCA1 and BRCA2: 1994 and beyond. Nat Rev Cancer 2004; 4:665-76; PMID:15343273; http://dx.doi.org/10.1038/nrc1431
   PubMed Web of Science ®Google Scholar
• Khanna KK, Jackson SP. DNA double-strand breaks: signaling, repair and the cancer connection. Nat Genet 2001; 27:247-54; PMID:11242102; http://dx.doi.org/10.1038/85798
   PubMed Web of Science ®Google Scholar
• Venkitaraman AR. Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 2002; 108:171-82; PMID:11832208; http://dx.doi.org/10.1016/S0092-8674(02)00615-3
   PubMed Web of Science ®Google Scholar
• Scully R, Livingston DM. In search of the tumour-suppressor functions of BRCA1 and BRCA2. Nature 2000; 408:429-32; PMID:11100717; http://dx.doi.org/10.1038/35044000
   PubMed Web of Science ®Google Scholar
• Ogawa T, Yu X, Shinohara A, Egelman EH. Similarity of the yeast RAD51 filament to the bacterial RecA filament. Science 1993; 259:1896-9; PMID:8456314; http://dx.doi.org/10.1126/science.8456314
   PubMed Web of Science ®Google Scholar
• Thacker J. The RAD51 gene family, genetic instability and cancer. Cancer letters 2005; 219:125-35; PMID:15723711; http://dx.doi.org/10.1016/j.canlet.2004.08.018
   PubMed Web of Science ®Google Scholar
• Lin Z, Kong H, Nei M, Ma H. Origins and evolution of the recA/RAD51 gene family: evidence for ancient gene duplication and endosymbiotic gene transfer. Proc Natl Acad Sci U S A 2006; 103:10328-33; PMID:16798872; http://dx.doi.org/10.1073/pnas.0604232103
   PubMed Web of Science ®Google Scholar
• Albala JS, Thelen MP, Prange C, Fan W, Christensen M, Thompson LH, Lennon GG. Identification of a novel human RAD51 homolog, RAD51B. Genomics 1997; 46:476-9; PMID:9441753; http://dx.doi.org/10.1006/geno.1997.5062
   PubMed Web of Science ®Google Scholar
• Cartwright R, Tambini CE, Simpson PJ, Thacker J. The XRCC2 DNA repair gene from human and mouse encodes a novel member of the recA/RAD51 family. Nucleic Acids Res 1998; 26:3084-9; PMID:9628903; http://dx.doi.org/10.1093/nar/26.13.3084
   PubMed Web of Science ®Google Scholar
• Dosanjh MK, Collins DW, Fan W, Lennon GG, Albala JS, Shen Z, Schild D. Isolation and characterization of RAD51C, a new human member of the RAD51 family of related genes. Nucleic Acids Res 1998; 26:1179-84; PMID:9469824; http://dx.doi.org/10.1093/nar/26.5.1179
   PubMed Web of Science ®Google Scholar
• Pittman DL, Weinberg LR, Schimenti JC. Identification, characterization, and genetic mapping of Rad51d, a new mouse and human RAD51/RecA-related gene. Genomics 1998; 49:103-11; PMID:9570954; http://dx.doi.org/10.1006/geno.1998.5226
   PubMed Web of Science ®Google Scholar
• Masson JY, Tarsounas MC, Stasiak AZ, Stasiak A, Shah R, McIlwraith MJ, Benson FE, West SC. Identification and purification of two distinct complexes containing the five RAD51 paralogs. Gen Dev 2001; 15:3296-307; PMID:11751635; http://dx.doi.org/10.1101/gad.947001
   PubMed Web of Science ®Google Scholar
• French CA, Tambini CE, Thacker J. Identification of functional domains in the RAD51L2 (RAD51C) protein and its requirement for gene conversion. J Biol Chem 2003; 278:45445-50; PMID:12966089; http://dx.doi.org/10.1074/jbc.M308621200
   PubMed Web of Science ®Google Scholar
• Kuznetsov SG, Haines DC, Martin BK, Sharan SK. Loss of Rad51c leads to embryonic lethality and modulation of Trp53-dependent tumorigenesis in mice. Cancer Res 2009; 69:863-72; PMID:19155299; http://dx.doi.org/10.1158/0008-5472.CAN-08-3057
   PubMed Web of Science ®Google Scholar
• Tsuzuki T, Fujii Y, Sakumi K, Tominaga Y, Nakao K, Sekiguchi M, Matsushiro A, Yoshimura Y, Morita T. Targeted disruption of the Rad51 gene leads to lethality in embryonic mice. Proc Natl Acad Sci U S A 1996; 93:6236-40; PMID:8692798; http://dx.doi.org/10.1073/pnas.93.13.6236
   PubMed Web of Science ®Google Scholar
• Liu N, Lamerdin JE, Tebbs RS, Schild D, Tucker JD, Shen MR, Brookman KW, Siciliano MJ, Walter CA, Fan W, et al. XRCC2 and XRCC3, new human Rad51-family members, promote chromosome stability and protect against DNA cross-links and other damages. Mol Cell 1998; 1:783-93; PMID:9660962; http://dx.doi.org/10.1016/S1097-2765(00)80078-7
   PubMed Web of Science ®Google Scholar
• Takata M, Sasaki MS, Tachiiri S, Fukushima T, Sonoda E, Schild D, Thompson LH, Takeda S. Chromosome instability and defective recombinational repair in knockout mutants of the five Rad51 paralogs. Mol Cell Biol 2001; 21:2858-66; PMID:11283264; http://dx.doi.org/10.1128/MCB.21.8.2858-2866.2001
   PubMed Web of Science ®Google Scholar
• French CA, Masson JY, Griffin CS, O'Regan P, West SC, Thacker J. Role of mammalian RAD51L2 (RAD51C) in recombination and genetic stability. J Biol Chem 2002; 277:19322-30; PMID:11912211; http://dx.doi.org/10.1074/jbc.M201402200
   PubMed Web of Science ®Google Scholar
• Gruver AM, Miller KA, Rajesh C, Smiraldo PG, Kaliyaperumal S, Balder R, Stiles KM, Albala JS, Pittman DL. The ATPase motif in RAD51D is required for resistance to DNA interstrand crosslinking agents and interaction with RAD51C. Mutagenesis 2005; 20:433-40; PMID:16236763; http://dx.doi.org/10.1093/mutage/gei059
   PubMed Web of Science ®Google Scholar
• Godthelp BC, Wiegant WW, van Duijn-Goedhart A, Scharer OD, van Buul PP, Kanaar R, Zdzienicka MZ. Mammalian Rad51C contributes to DNA cross-link resistance, sister chromatid cohesion and genomic stability. Nucleic Acids Res 2002; 30:2172-82; PMID:12000837; http://dx.doi.org/10.1093/nar/30.10.2172
   PubMed Web of Science ®Google Scholar
• Yoshihara T, Ishida M, Kinomura A, Katsura M, Tsuruga T, Tashiro S, Asahara T, Miyagawa K. XRCC3 deficiency results in a defect in recombination and increased endoreduplication in human cells. EMBO J 2004; 23:670-80; PMID:14749735; http://dx.doi.org/10.1038/sj.emboj.7600087
   PubMed Web of Science ®Google Scholar
• Renglin Lindh A, Schultz N, Saleh-Gohari N, Helleday T. RAD51C (RAD51L2) is involved in maintaining centrosome number in mitosis. Cytogenet Genome Res 2007; 116:38-45; PMID:17268176; http://dx.doi.org/10.1159/000097416
   PubMed Web of Science ®Google Scholar
• Brenneman MA, Weiss AE, Nickoloff JA, Chen DJ. XRCC3 is required for efficient repair of chromosome breaks by homologous recombination. Mutat Res 2000; 459:89-97; PMID:10725659; http://dx.doi.org/10.1016/S0921-8777(00)00002-1
   PubMed Web of Science ®Google Scholar
• Cui X, Brenneman M, Meyne J, Oshimura M, Goodwin EH, Chen DJ. The XRCC2 and XRCC3 repair genes are required for chromosome stability in mammalian cells. Mutat Res 1999; 434:75-88; PMID:10422536; http://dx.doi.org/10.1016/S0921-8777(99)00010-5
   PubMed Web of Science ®Google Scholar
• Wiegmans AP, Al-Ejeh F, Chee N, Yap PY, Gorski JJ, Da Silva L, Bolderson E, Chenevix-Trench G, Anderson R, Simpson PT, et al. Rad51 supports triple negative breast cancer metastasis. Oncotarget 2014; 5:3261-72; PMID:24811120; http://dx.doi.org/10.18632/oncotarget.1923
   PubMed Web of Science ®Google Scholar
• Wiegmans AP, Miranda M, Wen SW, Al-Ejeh F, Moller A. RAD51 inhibition in triple negative breast cancer cells is challenged by compensatory survival signaling and requires rational combination therapy. Oncotarget 2016 [epub ahead of print]; PMID:27507046
   PubMed Web of Science ®Google Scholar
• Bric A, Miething C, Bialucha CU, Scuoppo C, Zender L, Krasnitz A, Xuan Z, Zuber J, Wigler M, Hicks J, et al. Functional identification of tumor-suppressor genes through an in vivo RNA interference screen in a mouse lymphoma model. Cancer Cell 2009; 16:324-35; PMID:19800577; http://dx.doi.org/10.1016/j.ccr.2009.08.015
   PubMed Web of Science ®Google Scholar
• Meindl A, Hellebrand H, Wiek C, Erven V, Wappenschmidt B, Niederacher D, Freund M, Lichtner P, Hartmann L, Schaal H, et al. Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene. Nat Genet 2010; 42:410-4; PMID:20400964; http://dx.doi.org/10.1038/ng.569
   PubMed Web of Science ®Google Scholar
• Romero A, Perez-Segura P, Tosar A, Garcia-Saenz JA, Diaz-Rubio E, Caldes T, de la Hoya M. A HRM-based screening method detects RAD51C germ-line deleterious mutations in Spanish breast and ovarian cancer families. Breast Cancer Res Treat 2011; 129:939-46; PMID:21537932; http://dx.doi.org/10.1007/s10549-011-1543-x
   PubMed Web of Science ®Google Scholar
• Vuorela M, Pylkas K, Hartikainen JM, Sundfeldt K, Lindblom A, von Wachenfeldt Wappling A, Haanpaa M, Puistola U, Rosengren A, Anttila M, et al. Further evidence for the contribution of the RAD51C gene in hereditary breast and ovarian cancer susceptibility. Breast Cancer Res Treat 2011; 130:1003-10; PMID:21750962; http://dx.doi.org/10.1007/s10549-011-1677-x
   PubMed Web of Science ®Google Scholar
• Barlund M, Monni O, Kononen J, Cornelison R, Torhorst J, Sauter G, Kallioniemi O-P, Kallioniemi A. Multiple genes at 17q23 undergo amplification and overexpression in breast cancer. Cancer Res 2000; 60:5340-4; PMID:11034067
   PubMed Web of Science ®Google Scholar
• Sinclair CS, Rowley M, Naderi A, Couch FJ. The 17q23 amplicon and breast cancer. Breast Cancer Res Treat 2003; 78:313-22; PMID:12755490; http://dx.doi.org/10.1023/A:1023081624133
   PubMed Web of Science ®Google Scholar
• Wu GJ, Sinclair CS, Paape J, Ingle JN, Roche PC, James CD, Couch FJ. 17q23 amplifications in breast cancer involve the PAT1, RAD51C, PS6K, and SIGma1B genes. Cancer Res 2000; 60:5371-5; PMID:11034073
   PubMed Web of Science ®Google Scholar
• Yuan SS, Lee SY, Chen G, Song M, Tomlinson GE, Lee EY. BRCA2 is required for ionizing radiation-induced assembly of Rad51 complex in vivo. Cancer Res 1999; 59:3547-51; PMID:10446958
   PubMed Web of Science ®Google Scholar
• Sharan SK, Morimatsu M, Albrecht U, Lim DS, Regel E, Dinh C, Sands A, Eichele G, Hasty P, Bradley A. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature 1997; 386:804-10; PMID:9126738; http://dx.doi.org/10.1038/386804a0
   PubMed Web of Science ®Google Scholar
• Scully R, Chen J, Plug A, Xiao Y, Weaver D, Feunteun J, Ashley T, Livingston DM. Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 1997; 88:265-75; PMID:9008167; http://dx.doi.org/10.1016/S0092-8674(00)81847-4
   PubMed Web of Science ®Google Scholar
• Bennett BT, Knight KL. Cellular localization of human Rad51C and regulation of ubiquitin-mediated proteolysis of Rad51. J Cell Biochem 2005; 96:1095-109; PMID:16215984; http://dx.doi.org/10.1002/jcb.20640
   PubMed Web of Science ®Google Scholar
• Gildemeister OS, Sage JM, Knight KL. Cellular redistribution of Rad51 in response to DNA damage: novel role for Rad51C. J Biol Chem 2009; 284:31945-52; PMID:19783859; http://dx.doi.org/10.1074/jbc.M109.024646
   PubMed Web of Science ®Google Scholar
• Suwaki N, Klare K, Tarsounas M. RAD51 paralogs: roles in DNA damage signalling, recombinational repair and tumorigenesis. Semin Cell Dev Biol 2011; 22:898-905; PMID:21821141; http://dx.doi.org/10.1016/j.semcdb.2011.07.019
   PubMed Web of Science ®Google Scholar
• Vaz F, Hanenberg H, Schuster B, Barker K, Wiek C, Erven V, Neveling K, Endt D, Kesterton I, Autore F, et al. Mutation of the RAD51C gene in a Fanconi anemia-like disorder. Nat Genet 2010; 42:406-9; PMID:20400963; http://dx.doi.org/10.1038/ng.570
   PubMed Web of Science ®Google Scholar
• Badie S, Liao C, Thanasoula M, Barber P, Hill MA, Tarsounas M. RAD51C facilitates checkpoint signaling by promoting CHK2 phosphorylation. J Cell Biol 2009; 185:587-600; PMID:19451272; http://dx.doi.org/10.1083/jcb.200811079
   PubMed Web of Science ®Google Scholar
• Bartek J, Lukas J. Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell 2003; 3:421-9; PMID:12781359; http://dx.doi.org/10.1016/S1535-6108(03)00110-7
   PubMed Web of Science ®Google Scholar
• Nevanlinna H, Bartek J. The CHEK2 gene and inherited breast cancer susceptibility. Oncogene 2006; 25:5912-9; PMID:16998506; http://dx.doi.org/10.1038/sj.onc.1209877
   PubMed Web of Science ®Google Scholar
• Meijers-Heijboer H, van den Ouweland A, Klijn J, Wasielewski M, de Snoo A, Oldenburg R, Hollestelle A, Houben M, Crepin E, van Veghel-Plandsoen M, et al. Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat Genet 2002; 31:55-9; PMID:11967536; http://dx.doi.org/10.1038/ng879
   PubMed Web of Science ®Google Scholar
• Cybulski C, Gorski B, Huzarski T, Masojc B, Mierzejewski M, Debniak T, Teodorczyk U, Byrski T, Gronwald J, Matyjasik J, et al. CHEK2 is a multiorgan cancer susceptibility gene. Am J Hum Genet 2004; 75:1131-5; PMID:15492928; http://dx.doi.org/10.1086/426403
   PubMed Web of Science ®Google Scholar
• Antoni L, Sodha N, Collins I, Garrett MD. CHK2 kinase: cancer susceptibility and cancer therapy - two sides of the same coin? Nat Rev Cancer 2007; 7:925-36; PMID:18004398; http://dx.doi.org/10.1038/nrc2251
   PubMed Web of Science ®Google Scholar
• Zhuang J, Zhang J, Willers H, Wang H, Chung JH, van Gent DC, Hallahan DE, Powell SN, Xia F. Checkpoint kinase 2-mediated phosphorylation of BRCA1 regulates the fidelity of nonhomologous end-joining. Cancer Res 2006; 66:1401-8; PMID:16452195; http://dx.doi.org/10.1158/0008-5472.CAN-05-3278
   PubMed Web of Science ®Google Scholar
• Williamson LM, Lees-Miller SP. Estrogen receptor alpha-mediated transcription induces cell cycle-dependent DNA double-strand breaks. Carcinogenesis 2011; 32:279-85; PMID:21112959; http://dx.doi.org/10.1093/carcin/bgq255
   PubMed Web of Science ®Google Scholar
• Hsu PY, Hsu HK, Lan X, Juan L, Yan PS, Labanowska J, Heerema N, Hsiao TH, Chiu YC, Chen Y, et al. Amplification of distant estrogen response elements deregulates target genes associated with tamoxifen resistance in breast cancer. Cancer Cell 2013; 24:197-212; PMID:23948299; http://dx.doi.org/10.1016/j.ccr.2013.07.007
   PubMed Web of Science ®Google Scholar
• Maruani DM, Spiegel TN, Harris EN, Shachter AS, Unger HA, Herrero-Gonzalez S, Holz MK. Estrogenic regulation of S6K1 expression creates a positive regulatory loop in control of breast cancer cell proliferation. Oncogene 2012; 31:5073-80; PMID:22286763; http://dx.doi.org/10.1038/onc.2011.657
   PubMed Web of Science ®Google Scholar
• Han HS, Yu E, Song JY, Park JY, Jang SJ, Choi J. The estrogen receptor alpha pathway induces oncogenic Wip1 phosphatase gene expression. Mol Cancer Res 2009; 7:713-23; PMID:19435816; http://dx.doi.org/10.1158/1541-7786.MCR-08-0247
   PubMed Web of Science ®Google Scholar
• Bhat-Nakshatri P, Wang G, Collins NR, Thomson MJ, Geistlinger TR, Carroll JS, Brown M, Hammond S, Srour EF, Liu Y, et al. Estradiol-regulated microRNAs control estradiol response in breast cancer cells. Nucleic Acids Res 2009; 37:4850-61; PMID:19528081; http://dx.doi.org/10.1093/nar/gkp500
   PubMed Web of Science ®Google Scholar
• Fan C, Oh DS, Wessels L, Weigelt B, Nuyten DS, Nobel AB, van't Veer LJ, Perou CM. Concordance among gene-expression-based predictors for breast cancer. N Engl J Med 2006; 355:560-9; PMID:16899776; http://dx.doi.org/10.1056/NEJMoa052933
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas N. Comprehensive molecular portraits of human breast tumours. Nature 2012; 490:61-70; PMID:23000897; http://dx.doi.org/10.1038/nature11412
   PubMed Web of Science ®Google Scholar
• Alayev A, Salamon RS, Berger SM, Schwartz NS, Cuesta R, Snyder RB, Holz MK. mTORC1 directly phosphorylates and activates ERalpha upon estrogen stimulation. Oncogene 2016; 35(27):3535–3543; PMID:26522726
   PubMedGoogle Scholar
• Tumiati M, Munne PM, Edgren H, Eldfors S, Hemmes A, Kuznetsov SG. Rad51c- and Trp53-double-mutant mouse model reveals common features of homologous recombination-deficient breast cancers. Oncogene 2016; 35:4601-10; PMID:26820992; http://dx.doi.org/10.1038/onc.2015.528
   PubMed Web of Science ®Google Scholar
• Gevensleben H, Bossung V, Meindl A, Wappenschmidt B, de Gregorio N, Osorio A, Romero A, Buettner R, Markiefka B, Schmutzler RK. Pathological features of breast and ovarian cancers in RAD51C germline mutation carriers. Virchows Arch 2014; 465:365-9; PMID:24993905; http://dx.doi.org/10.1007/s00428-014-1619-1
   PubMed Web of Science ®Google Scholar
• Woditschka S, Evans L, Duchnowska R, Reed LT, Palmieri D, Qian Y, Badve S, Sledge G, Jr., Gril B, Aladjem MI, et al. DNA double-strand break repair genes and oxidative damage in brain metastasis of breast cancer. J Natl Cancer Inst 2014; 106(7); PMID:24948741; http://dx.doi.org/10.1093/jnci/dju145
   PubMedGoogle Scholar
• Yata K, Bleuyard JY, Nakato R, Ralf C, Katou Y, Schwab RA, Niedzwiedz W, Shirahige K, Esashi F. BRCA2 coordinates the activities of cell-cycle kinases to promote genome stability. Cell Rep 2014; 7:1547-59; PMID:24835992; http://dx.doi.org/10.1016/j.celrep.2014.04.023
   PubMed Web of Science ®Google Scholar
• Gudmundsdottir K, Ashworth A. The roles of BRCA1 and BRCA2 and associated proteins in the maintenance of genomic stability. Oncogene 2006; 25:5864-74; PMID:16998501; http://dx.doi.org/10.1038/sj.onc.1209874
   PubMed Web of Science ®Google Scholar
• Jordan VC. The new biology of estrogen-induced apoptosis applied to treat and prevent breast cancer. Endocr Relat Cancer 2015; 22:R1-31; PMID:25339261; http://dx.doi.org/10.1530/ERC-14-0448
   PubMed Web of Science ®Google Scholar
• Min A, Im SA, Yoon YK, Song SH, Nam HJ, Hur HS, Kim HP, Lee KH, Han SW, Oh DY, et al. RAD51C-deficient cancer cells are highly sensitive to the PARP inhibitor olaparib. Mol Cancer Ther 2013; 12:865-77; PMID:23512992; http://dx.doi.org/10.1158/1535-7163.MCT-12-0950
   PubMed Web of Science ®Google Scholar
• Kim H, Tarhuni A, Abd Elmageed ZY, Boulares AH. Poly(ADP-ribose) polymerase as a novel regulator of 17beta-estradiol-induced cell growth through a control of the estrogen receptor/IGF-1 receptor/PDZK1 axis. J Translat Med 2015; 13:233; PMID:26183824; http://dx.doi.org/10.1186/s12967-015-0589-7
   PubMed Web of Science ®Google Scholar
• Yamnik RL, Digilova A, Davis DC, Brodt ZN, Murphy CJ, Holz MK. S6 kinase 1 regulates estrogen receptor alpha in control of breast cancer cell proliferation. J Biol Chem 2009; 284:6361-9; PMID:19112174; http://dx.doi.org/10.1074/jbc.M807532200
   PubMed Web of Science ®Google Scholar
• Alayev A, Sun Y, Snyder RB, Berger SM, Yu JJ, Holz MK. Resveratrol prevents rapamycin-induced upregulation of autophagy and selectively induces apoptosis in TSC2-deficient cells. Cell cycle 2014; 13:371-82; PMID:24304514; http://dx.doi.org/10.4161/cc.27355
   PubMed Web of Science ®Google Scholar